XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Compensation  
Schedule of share-based compensation expense category

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands)

    

2023

    

2022

2023

    

2022

Research and development

$

1,429

$

568

$

4,788

$

6,528

General and administrative

 

1,395

 

2,294

 

4,563

 

8,949

$

2,824

$

2,862

$

9,351

$

15,477

Summary of stock option activity plan

    

    

    

Weighted

Weighted

average

average

remaining

Number of

exercise price

contractual

shares

per share

term (years)

Outstanding at January 1, 2023

 

11,411,390

 

$

9.01

 

7.1

Granted

 

3,348,982

1.06

 

  

Exercised

 

 

  

Forfeited

 

(2,256,315)

8.58

 

  

Expired

 

(2,264,006)

12.50

 

  

Outstanding at September 30, 2023

 

10,240,051

$

5.73

 

8.2

Vested and exercisable at September 30, 2023

 

4,935,214

$

8.43

 

7.4

Vested or expected to vest at September 30, 2023

 

10,240,051

$

5.73

 

8.2

Schedule of weighted average assumptions applied to options

Nine Months Ended September 30, 

2023

2022

Expected volatility

92.6

%  

92.3

%

Risk‑free interest rate

3.6

%

2.6

%

Expected term

6.0

years

5.8

years

Expected dividend yield

Summary of activity related to restricted stock unit

    

    

Weighted average

 

Number of shares

 

grant date fair value

Unvested balance at January 1, 2022

 

1,229,166

 

$

2.98

Granted

 

195,000

 

$

1.01

Vested

(98,042)

5.82

Forfeited

 

(179,625)

 

$

2.13

Unvested balance at September 30, 2023

 

1,146,499

 

$

2.58